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Abstract
Background The number of elderly patients suffering from esophageal cancer is increasing, due to an increasing incidence of
esophageal cancer and increasing life expectancy. However, the effect of age on morbidity, mortality, and survival after Ivor
Lewis total minimally invasive esophagectomy (TMIE) is not well known.
Methods A prospectively documented database from December 2010 to June 2017 was analyzed, including all patients who
underwent Ivor Lewis TMIE for esophageal cancer in three Dutch high-volume esophageal cancer centers. Patients younger than
75 years (younger group) were compared to patients aged 75 years or older (elderly group). Baseline patient characteristics and
perioperative data were included. Surgical complications were graded using the Clavien-Dindo scale. The primary outcome was
postoperative complications Clavien-Dindo ≥ 3. Secondary outcome parameters were postoperative complications, in-hospital
mortality, 30- and 90-day mortality and survival.
Results Four hundred and forty-six patients were included, 357 in the younger and 89 in the elderly group. No significant
differences were recorded regarding baseline patient characteristics. There was no significant difference in complications graded
Clavien-Dindo ≥ 3 and overall complications, short-term mortality, and survival. Delirium occurred in 27.0% in the elderly and
11.8% in the younger group (p < 0.001). After correction for baseline comorbidity this difference remained significant
(p = 0.001). Median hospital length of stay was 13 days in the elderly and 11 days in the younger group (p = 0.010).
Conclusions Ivor Lewis TMIE can be safely performed in selected elderly patients without increasing postoperative morbidity
and mortality.
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Introduction
The incidence of esophageal cancer is increasing, with a current
incidence of 455,000 worldwide.1 The number of elderly pa-
tients diagnosed with esophageal cancer is increasing mainly
due to an increased life expectancy of the general population.
Esophageal resection with gastric conduit reconstruction after
neoadjuvant therapy is the treatment of choice for patients with
resectable esophageal carcinoma.2, 3 Esophagectomy is associ-
ated with considerable morbidity and mortality and this might
be higher for elderly patients since they are more frail and
generally have more comorbidities than younger patients.4, 5
Previous studies focusing on age-related morbidity and
mortality regarding esophagectomy included patients that
had been treated with open esophageal resection and showed
that elderly patients have an increased peri-operative and in-
hospital mortality risk, developed more postoperative
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complications and ultimately are confronted with a decreased
5-year survival rate.6, 7 Other studies, however, show no sig-
nificant differences regarding short-term mortality and
survival.8, 9 Nonetheless, most of these studies were single-
center experiences, reported on small numbers of patients,
included heterogeneous surgical approaches and very few
underwent minimally invasive esophagectomy.6–9 Both a total
minimally invasive esophagectomy (TMIE) and an Ivor
Lewis approach have been shown to be associated with less
postoperative morbidity compared with an open esophagecto-
my and a McKeown approach.10–12 Several studies regarding
colon cancer have shown that laparoscopic assisted colectomy
is associated with less postoperative morbidity when com-
pared to open colectomy in elderly patients.13, 14 However, it
is currently unknown whether or not a minimal invasive Ivor
Lewis esophagectomy is also associated with acceptable mor-
bidity for older patients.
Therefore, the objective of this study was to analyze the
influence of age on short- and long-term outcomes after Ivor
Lewis TMIE.
Material and Methods
Patients
All patients with esophageal carcinoma undergoing elective
Ivor Lewis TMIE with curative intent were included. Patients
aged ≥ 75 years (elderly group) were compared with patients
< 75 years (younger group). The cutoff value of 75 years was
chosen, because patients aged ≥ 75 years are generally exclud-
ed from clinical trials (including the TIME andMIRO trial).10,
11 Patients were operated on in three high-volume esophageal
cancer centers in the Netherlands (Canisius-Wilhelmina
hospital Nijmegen, Catharina hospital Eindhoven and ZGT
hospital Almelo) from December 2010 to June 2017.
Study Design
The three participating hospitals entered data of all esophageal
cancer patients undergoing surgery into a prospective data-
base. Data on patient-, tumor-, and operative characteristics,
neoadjuvant treatment, postoperative complications, length of
hospital and ICU stay, readmissions, postoperative mortality,
pathology results, and overall survival were retrospectively
analyzed.
Outcome Parameters
The primary outcome parameter was complications graded ≥
III according to the Clavien-Dindo (CD) classification.15
Secondary outcome parameters were the associated failure to
rescue (FTR), CD complications graded < II, in-hospital
mortality, 30- and 90-day mortality, failure to rescue, and
long-term survival.
Definitions
Postoperative complications studied were pulmonary compli-
cations, cardiac complications, and other specified complica-
tions. Pulmonary complications were defined as the combined
incidence of pneumothorax, pleural empyema, pleural effu-
sion, a small group of other, less frequently diagnosed pulmo-
nary complications called Bother pulmonary complications,^
and clinically diagnosed pneumonia defined according to the
revised Uniform Pneumonia Score (r-UPS) for which treat-
ment was started.16 Cardiac complications included atrial fi-
brillation, myocardial infarction, asystoly, and pericarditis, di-
agnosed by electrocardiogram, ultrasound, and/or laboratory
findings. To account for cardiac complications that were not
listed, and which are not as frequently diagnosed, those com-
plications were combined in a small group of Bother cardiac
complications.^ Other postoperative complications that were
recorded included anastomotic leakage defined according to
the Esophageal Complications Consensus Group (ECCG),17
delirium, jejunostomy (JJS)-related complications, urinary
tract infection (UTI), urine retention, thrombo-embolic (TE)
events, cerebrovascular accidents (CVA), chylothorax, and
bronchoesophageal (BE) fistula.
Complications that could be directly attributed to the spe-
cific surgical process of an esophagectomy were considered to
be Btechnical^ and consisted of anastomotic leakage,
chylothorax, and BE fistula. More general complications, oc-
curring during hospital stay, were defined as Bclinical^ com-
plications and included pulmonary complications, cardiac
complications, delirium, CVA, UTI/urine retention, and TE
events. In hospital, mortality was defined as any death occur-
ring during hospital admittance. In addition, the 30-day, 90-
day mortality, 1-year, and 2-year survival rates were analyzed.
Operative Technique
Ivor Lewis TMIE consisted of laparothoracoscopic resection
with intrathoracic esophagogastrostomy.18 Three types of in-
trathoracic anastomosis were used: 1) a linear stapled side-to-
side (S-S) anastomosis, 2) a circular stapled end-to-side (E-S)
anastomosis, or a handsewn end-to-end (E-E) anastomosis.
Statistical Analysis
Statistical analysis was performed with the SPSS software
package, version 24.0 (SPSS Inc., IBM Corporation
Software Group, Somers, NY, USA). For dichotomous or or-
dinal variables, the Pearson’s chi-square test or Fisher’s exact
test was used when appropriate. For non-normally distributed
data, the Mann-Whitney U test was used. All tests were two-
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Table 1 Patient characteristics
Patients < 75 years Patients ≥ 75 years p value
N = 357 (%) N = 89 (%)
Hospital 0.041
–1 148 (41.5%) 32 (36.0%)
–2 163 (45.7%) 36 (40.4%)
–3 46 (12.9%) 21 (23.6%)
BMI 0.158
–Median/IQR 25.7 (5.4) 24.7 (3.8)
Age < 0.001
0.158median/IQR 63.5 (10.3) 75.9 (3.3)
Sex 0.625
–Male 293 (82.1%) 75 (84.3%)
–Female 64 (17.9%) 14 (15.7%)
ASA classification 0.063
–1 42 (11.8%) 5 (5.6%)
–2 293 (66.9%) 56 (62.9%)
–3 73 (20.4%) 28 (31.5%)
–4 3 (0.8%) 0 (0.0%)
Charlson Co-morbidity Index score (three groups) 0.058
–0 202 (56.6%) 38 (42.7%)
–1 90 (25.2%) 28 (31.5%)
–≥ 2 65 (18.2) 23 (25.8%)
Neoadjuvant therapy 0.584
–Chemoradiotherapy 331 (92.7%) 80 (89.9%)
–Chemotherapy 8 (2.2%) 2 (2.2%)
–Radiotherapy 0 (0.0%) 0 (0.0%)
–None 18 (5.0%) 7 (7.9%)
Tumor stage 0.845*
–I 96 (26.9%) 25 (28.1%)
–II 160 (44.8%) 40 (44.9%)
–III 101 (28.3%) 22 (24.7%)
–IV 0 (0.0%) 0 (0.0%)
Tumor type 0.083
–SCC 49 (13.7%) 9 (10.1%)
–Adenocarcinoma 300 (84.0%) 78 (87.6%)
–Other 7 (2.0%) 0 (0.0%)
–Unable to specify 1 (0.3%) 2 (2.2%)
Tumor location 0.239
–Mid esophagus 25 (7.0%) 4 (4.5%)
–Distal esophagus 253 (70.9%) 71 (79.8%)
–Junction 79 (22.1%) 14 (15.7%)
Anastomotic configuration 1.000
–End to end 4 (1.1%) 1 (1.1%)
–End to side 177 (49.6%) 44 (49.4%)
–Side to side 176 (49.3%) 44 (49.4%)
Anastomotic technique 0.170
–Handsewn 31 (8.7%) 12 (13.5%)
–Stapled 326 (91.3%) 77 (86.5%)
*Patients from whom clinical stage could not be assessed were excluded. Total: 2
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sided, and p values less than 0.05 were considered to be sta-
tistically significant. Binominal logistic regression analysis
was used when differences in case mix parameters between
the groups were associated with p values of < 0.1, to adjust for
bias from differences in baseline patient characteristics. The
Kaplan-Meier method was used to estimate the 1- and 2-year
survival, with the Mantel-Cox log-rank test to determine
whether there were statistically significant differences be-
tween the groups. In addition to the main analysis, hospital
length of stay (LOS) was compared between elderly and
younger patients in a subgroup that experienced complications
and a subgroup that experienced severe complications, to
evaluate whether there were any differences in how patients
recover from complications.
Results
Some 446 patients were enrolled and analyzed. Three hundred
and fifty-seven patients were younger than 75 years (younger
group) and 89 patients were aged 75 years and older (elderly
group).
Patient and Operation Characteristics
There was a trend towards a higher CCI score in the elderly
group (p = 0.058, Table 1). ASA III tended to be higher in the
elderly group (p = 0.063, Table 1). Other patient characteris-
tics and operation characteristics did not differ significantly
between the groups (Table 1 and Table 2).
Postoperative Outcome Parameters
Postoperative complications are shown in Table 3. There was
no significant difference between the younger group and the
elderly group regarding severe complications (35.9% in the
younger group versus 43.8% in the elderly group, p = 0.421).
Regarding the associated FTR, the younger group (8.6%) and
the elderly group (11.1%) did not significantly differ (p =
0.743). The incidence of overall complications was 72.8% in
the younger group versus 79.8% in the elderly group (p =
0.180). The incidence of technical complications was 24.6%
in the younger group and 25.8% in the elderly group (p =
0.816) and clinical complications (69.7% versus 76.4%; p =
0.215). The incidence of cardiovascular complications was
higher in the elderly group (14.0% versus 24.7%; p = 0.014).
Other complications, reoperation rate, reintervention rate, and
(ICU) length of stay did not significantly differ between the
two groups. The incidence of postoperative delirium was 27%
in the elderly group and 11.8% the younger group (p =
<0.001). These differences persisted in binary logistic regres-
sion analyses correcting for comorbidity and ASA score. In
addition, median hospital length of stay (LOS) was signifi-
cantly shorter in the younger group than in the elderly group
(11 versus 13 days, p = 0.010).
In both a subset of patients that experienced postoperative
complications and a subset of patients that experienced severe
complications, the median hospital LOS did not differ signif-
icantly between the elderly group and the younger group.
Mortality and Survival
In-hospital mortality was 3.1% in the younger group versus
3.4% in the elderly group (p = 0.513) and 30-day mortality
was 2.8% in the younger group versus 2.2% in the elderly
group (p = 0.889). Ninety-day mortality was 5.0% in the
younger group versus 9.0% in the elderly group (p = 0.155)
(Table 4).
One-year survival was 77.9% in the younger group versus
76.4% in the elderly group (p = 0.767) and 2-year survival
was 54.5% in the younger group and 57.3% in the elderly
group (p = 0.666) (Fig. 1).
Table 2 Operation and pathology
characteristics Patients < 75 years Patients ≥ 75 years p value
N = 357 (%) N = 89 (%)
Abdominal conversion 7 (2.0%) 3 (3.4%) 0.425
Thoracic conversion 8 (2.2%) 3 (3.4%) 0.465
Operation time (min)
–Median/IQR 252 (85) 278 (100) 0.064
Peri-operative blood loss (mL)
–Median/IQR 100 (120) 100 (100) 0.938*
Lymph nodes
–Median/IQR 21 (11) 20 (9) 0.424
R0-resection 340 (95.2%) 81 (91%) 0.121
Complete pathological response 60 (16.8%) 16 (18.0%) 0.793
*Patients from whom blood loss could not be assessed were excluded. Total: 18, 2 from the elderly group and 16
from the younger group
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Table 3 Postoperative
complications and length of stay Patients
< 75 years
Patients
≥ 75 years
p
value
Adjusted p
value*
Odds (95%-BI)
N = 357 (%) N = 89 (%)
Severe complications
(CD ≥ 3)
128 (35.9) 39 (43.8) 0.421 0.625 1.13 (0.70, 1.83)
–FTR** 11 (8.6) 4 (11.1) 0.743 0.721 1.25 (0.37, 4.28)
Anastomotic leakage 61 (17.1) 17 (19.1) 0.654 0.715 1.12 (0.61, 2.03)
–Grade 1 5 (1.4) 3 (3.4) 0.201 0.256 2.32 (0.54, 9.95)
–Grade 2 33 (9.2) 8 (9.0) 0.941 0.881 0.94 (0.42, 2.12)
–Grade 3 23 (6.4) 6 (6.7) 0.918 0.899 1.06 (0.42, 2.70)
Chyle leakage 29 (8.1) 7 (7.9%) 0.936 0.940 0.97 (0.41, 2.29)
Esophagobronchial
fistula
5 (1.4) 1 (1.1%) 1.000 0.658 0.61 (0.07, 5.44)
Pulmonary
complications
222 (62.2) 56 (62.9) 0.989 0.979 0.99 (0.61, 1.61)
–Pneumonia 117 (32.8) 28 (31.5) 0.813 0.678 0.90 (0.54, 1.49)
–Empyema 42 (11.8) 10 (11.2) 0.889 0.863 0.94 (0.45, 1.96)
–Pneumothorax 58 (16.2) 11 (12.4) 0.364 0.320 0.70 (0.35, 1.41)
–Pleural effusion 93 (26.1) 26 (29.2) 0.546 0.550 1.17 (0.70, 1.96)
–Other 68 (19.0) 17 (19.1) 0.991 0.964 0.99 (0.55, 1.79)
Cardiac complications 50 (14.0%) 22 (24.7%) 0.014 0.019 1.98 (1.11, 3.50)
–AF 41 (11.5%) 17 (19.1%) 0.056 0.063 1.81 (0.97, 3.38)
–MI 2 (0.6%) 2 (2.2%) 0.179 0.124 4.79 (0.65, 35.20)
–Asystoly 5 (1.4%) 0 (0.0%) 0.588 0.997 0.00 (0.00, ∞)
–Pericarditis 1 (0.3%) 0 (0.0%) 1.000 0.997 0.00 (0.00, ∞)
–Other 5 (1.4%) 7 (7.9%) 0.003 0.003 6.09 (1.86, 19.90)
Other complications 99 (27.7) 39 (43.8) 0.003 0.006 1.98 (1.22, 3.20)
–Delirium 42 (11.8) 24 (27.0) 0.000 0.001 2.63 (1.48, 4.66)
–JJS related*** 26 (7.3) 11 (12.4) 0.120 0.141 1.76 (0.83, 3.72)
–UTI/retention 10 (2.8) 4 (4.5%) 0.493 0.398 1.67 (0.51, 5.52)
–Trombo-embolic 8 (2.2) 2 (2.2%) 1.000 0.965 0.97 (0.20, 4.67)
–CVA 3 (0.8) 2 (2.2%) 0.261 0.250 2.91 (0.47, 18.04)
Total complication rate 260 (72.8) 71 (79.8) 0.180 0.228 1.42 (0.80, 2.51)
Technical complications 88 (24.6) 23 (25.8) 0.816 0.895 1.04 (0.61, 1.77)
Clinical complications 249 (69.7) 68 (76.4) 0.215 0.273 1.35 (0.79, 2.33)
Reintervention 114 (31.9) 33 (37.1) 0.355 0.425 1.22 (0.75, 1.98)
Reoperation 78 (21.9) 16 (18.0) 0.416 0.350 0.75 (0.41, 1.37)
Radiologic
reintervention
48 (13.4) 8 (9.0) 0.256 0.253 0.63 (0.29, 1.39)
Endoscopic
reintervention
47 (13.2) 18 (20.2) 0.095 0.087 1.70 (0.93, 3.12)
Re-intubation 34 (9.5%) 14 (15.7) 0.091 0.150 1.65 (0.83, 3.27)
ICU LOS (days)
–Median/IQR 2 (3) 2 (5) 0.305
ICU readmission 68 (19.0%) 17 (19.1%) 0.991 0.854 0.95 (0.52, 1.72)
Hospital LOS (days)
–Median/IQR 11 (11) 13 (17) 0.010
Hospital LOS > 21 days 81 (22.7) 28 (31.5) 0.085 0.112 1.52 (0.91, 2.54)
Hospital Readmission 58 (16.2%) 13 (14.6%) 0.705 0.561 0.82 (0.43, 1.59)
*p value adjusted for ASA and CCI score after binomial logistic regression analysis
**Younger group N = 128 and elderly group N = 39
***Jejunostomy-related complications
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Discussion
This study shows that the incidence of overall and severe
complications (CD > 3) in this highly selected group of elderly
patients undergoing Ivor Lewis TMIE is not higher than in
younger patients. However, the incidence of cardiac compli-
cations and delirium were higher in the elderly group and
hospital LOS was longer. Overall, this study supports the hy-
pothesis that Ivor Lewis TMIE can be safely performed in
selected elderly patients. Age alone should therefore not be a
reason to withhold Ivor Lewis TMIE from patients.
The strengths of this study are, that this is one of the few
studies investigating the influence of age on postoperative mor-
bidity in a large multicenter outcome database and that this study
specifically included patients undergoing Ivor-Lewis TMIE. In
addition,we reported on a broad range of postoperative outcomes.
Limitations of this study are its retrospective character and the fact
that a relatively small number of elderly patients were included
compared to younger patients, limiting statistical power. In addi-
tion, the cohort of elderly patients in our study is a very selected
group, representing the healthiest patients in their population,
which is also underlined by the limited difference in baseline
comorbidity between elderly and younger patients.
Unfortunately, none of the participating hospitals used objective
and specified criteria for selecting the elderly patients for TMIE as
well as the younger patients and, therefore, we were unable to
determine what characteristics these patients were selected on,
and what characteristics lead to other definitive, non-surgical
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Table 4 Mortality and survival
Patients
< 75 years
Patients
≥ 75 years
p
value
Adjusted p
value*
Odds (95%-BI)
N = 357 (%) N = 89 (%)
In-hospital
mortality
11 (3.1) 4 (3.4) 0.513 0.591 1.38 (0.43, 4.48)
30-day mortality 10 (2.8) 2 (2.2) 1.000 0.699 0.74 (0.16, 3.46)
90-day mortality 18 (5.0) 8 (9.0) 0.155 0.208 1.75 (0.73, 4.20)
1-year survival 278 (77.9) 68 (76.4) 0.767 0.937 1.02 (0.59, 1.78)
2-year survival* 156 (54.5) 43 (57.3) 0.666 0.585 0.87 (0.52, 1.45)
*Patients < 75 years old N = 286; patients ≥ 75 years old N = 75
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treatment. Some elderly patients, initially deemed fit for surgery,
may had to drop out before operation, because of toxicity side
effects caused by the neoadjuvant chemoradiotherapy regimen.
Unfortunately, we were unable to calculate the drop-out rates for
both groups because data on drop-outs is not included in the
surgical database.However, since drop-out rates after neoadjuvant
chemoradiotherapy have been shown to be low in general (2–
8%), it is unlikely that these drop-out rates significantly influ-
enced our results.2, 19 More research is needed to investigate
what criteria should be used for objectively selecting patients
for curative esophageal surgery.
Studies on the influence of age in patients undergoing open
esophagectomy show conflicting results. While some studies
reported a higher incidence of non-surgical complications and
higher mortality in the elderly group,6, 7, 20 other studies
showed no difference in complications or mortality between
the younger and elderly age groups.8, 9 For minimally invasive
esophagectomy, a previous single-center study with 57 patients
showed no significant difference in adverse events, length of
stay, or mortality and which is grossly in line with the present
study.21 Elderly patients may specifically benefit fromminimal-
ly invasive esophagectomy, since it is associated with less post-
operative morbidity compared to open esophagectomy.10, 11
The incidence of anastomotic leakage in the current study did
not significantly differ between groups, but was higher than ob-
served in previous studies.21–24 This may be attributed to the fact
that, in the present study, all diagnosed anastomotic leaks were
included, while others only reported anastomotic leaks requiring
surgery representing only ECCG grade III leakages.22 The low
percentage of ECCG grade III leakage as reported in the latter
study (4.3%) was, however, comparable with our study (6.5%).
Furthermore, the learning curve of minimally invasive surgical
techniques may have played a role during the study period.25, 26
An important factor in the preoperative assessment of elderly
patients is the presence of comorbidities, which have a large
impact on the development of postoperative complications and
overall survival after esophagectomy.27 This underlines the im-
portance of assessing each potential candidate individually. In
our study, the elderly group did not show a difference in comor-
bidities or ASA score compared with the younger group, which
might be the result of the selection process. Although a longer
hospital length of stay and a higher incidence of cardiac com-
plications and delirium occurred in the elderly group, this obser-
vation did not result in a higher incidence of reinterventions,
mortality, or impaired survival—which is in line with other
studies.28, 29 Delirium, however, has a substantial negative im-
pact on hospital length of stay, quality of life, and costs.30 It also
increases the risk for institutionalization in a nursing home and
dementia.31 However, the incidence still might be an underesti-
mation, since delirium is often underdiagnosed.32 Several stud-
ies showed a positive effect on the incidence of postoperative
delirium with the help of special hospital programs and preop-
erative screening.33, 34 One randomized trial showed that
Bgeriatrics consultation reduced delirium by over one-third^
adding to the argument that active participation of a geriatrician
in the perioperative care process could be beneficial when deal-
ing with elderly patients undergoing esophagectomy.
Conclusion
Ivor Lewis TMIE can be safely performed in selected patients
aged ≥ 75 years, without increasing severe complications or
decreasing survival. Advanced age alone should not be a rea-
son to withhold Ivor Lewis TMIE from patients. More re-
search is needed to investigate what criteria should be used
for selecting and preparing elderly patients with curable
esophageal cancer for minimally invasive esophageal surgery.
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